Moviprep (Ascorbic Acid, Sodium Ascorbate, Potassium Chloride, Sodium Chloride, Sodium Sulfate Anhydrous, Macr)

Moviprep, an osmotic laxative used for bowel cleansing, is indicated for the following clinical situations:

• Colonoscopy preparation: provides rapid and thorough evacuation of the colon to enable clear visualization.
• Radiologic bowel examination: cleanses the colon before barium enema or CT colonography.
• Endoscopic procedures: prepares the bowel for flexible sigmoidoscopy or other lower GI endoscopies.

• Polyethylene glycol molecules are large, non‑absorbable polymers that remain in the intestinal lumen. When combined with electrolytes, they create an osmotic gradient that draws water into the bowel, increasing luminal volume and promoting rapid evacuation while maintaining electrolyte balance.

Moviprep may cause a range of adverse reactions, most of which are related to its osmotic activity and electrolyte content.

Common Side Effects

• Nausea: mild to moderate feeling of sickness.
• Abdominal bloating: sensation of fullness or distension.
• Vomiting: occasional expulsion of stomach contents.
• Diarrhea: loose stools during the cleansing process.

Serious or Rare Side Effects

• Severe electrolyte imbalance: abnormal sodium or potassium levels requiring medical attention.
• Dehydration: significant fluid loss leading to low blood pressure or dizziness.
• Allergic reaction: rash, itching, swelling, or difficulty breathing.

Before prescribing Moviprep, clinicians should consider several safety precautions to minimize risks.

• Renal impairment: assess kidney function because fluid shifts may exacerbate renal insufficiency.
• Cardiac disease: monitor patients with heart failure due to potential electrolyte disturbances.
• Electrolyte disorders: correct existing hyponatremia or hypokalemia before use.
• Gastrointestinal obstruction: avoid in patients with known or suspected bowel blockage.
• Pregnancy and lactation: use only if clearly needed, as safety data are limited.
• Store at room temperature: keep below 25°C, retain in original packaging and protect from moisture.

Moviprep can interact with other medicines, primarily through its effect on fluid and electrolyte balance.

Major Interactions (Avoid)

• Loop diuretics: may increase risk of dehydration and electrolyte loss.
• Sodium polystyrene sulfonate: can exacerbate sodium shifts leading to severe imbalance.

Moderate Interactions (Monitor Closely)

• Antihypertensives: monitor blood pressure as volume depletion may enhance hypotensive effect.
• Lithium: watch serum lithium levels because changes in sodium can affect lithium clearance.
• Oral iron supplements: may reduce efficacy of bowel cleansing if taken concurrently.